Area of research
Pulmonary and Respiratory Medicine · Oncology
Research interest
Research interests include Lung Cancer Treatments and Mutations, Cancer Immunotherapy and Biomarkers, Lung Cancer Research Studies, and Lung Cancer Diagnosis and Treatment.
Spatial immune scoring system predicts hepatocellular carcinoma recurrence
Taletrectinib in <i>ROS1</i> + Non–Small Cell Lung Cancer: TRUST
Sacituzumab Tirumotecan in EGFR-TKI–Resistant, <i>EGFR</i> -Mutated Advanced NSCLC
Expert consensus on the diagnosis and treatment of non-small cell lung cancer with MET alteration
Expert Consensus on the Diagnosis and Treatment of Malignant Mesothelioma of the Tunica Vaginalis Testis
RC108 in combination with furmonertinib in patients with locally advanced or metastatic EGFR-mutated non-small-cell lung cancer (NSCLC) with MET overexpression: Results from a phase Ib/II trial.
First in human phase I study of TQB2103, a Claudin18.2 (CLDN18.2) targeted antibody-drug conjugate (ADC), in patients with advanced solid tumors.
EML4-ALK fusions drive lung adeno-to-squamous transition through JAK-STAT activation
Expert Consensus on the Diagnosis and Treatment of NRG1/2 Gene Fusion Solid Tumors
Expert consensus on the diagnosis and treatment of solid tumors with BRAF mutations
Clinical best practices in interdisciplinary management of human epidermal growth factor receptor 2 antibody‐drug conjugates–induced interstitial lung disease/pneumonitis: An expert consensus in China
Crizotinib resistance reversal in ALK-positive lung cancer through zeolitic imidazolate framework-based mitochondrial damage
Expert Consensus on the Diagnosis and Treatment of FGFR Gene-Altered Solid Tumors
Divergent tumor and immune cell reprogramming underlying immunotherapy response and immune-related adverse events in lung squamous cell carcinoma
Chinese expert consensus on the diagnosis and treatment of thymic epithelial tumors
Chinese expert consensus on the diagnosis and treatment of malignant pleural mesothelioma
Expert consensus on treatment for stage III non‐small cell lung cancer
Expert consensus on the diagnosis and treatment of <scp>RET</scp> gene fusion <scp>non‐small</scp> cell lung cancer in <scp>China</scp>
Treatment outcomes and prognosis of immune checkpoint inhibitors therapy in patients with advanced thymic carcinoma: A multicentre retrospective study
Chinese expert consensus on the multidisciplinary management of pneumonitis associated with immune checkpoint inhibitor
Chinese expert consensus on the diagnosis and treatment of <scp>HER2</scp>‐altered non–small cell lung cancer
Expert consensus on the diagnosis and treatment of <scp><i>NTRK</i></scp> gene fusion solid tumors in China
Analysis of the efficacy and safety of immunotherapy in advanced thymoma patients
ADORA1 Inhibition Promotes Tumor Immune Evasion by Regulating the ATF3-PD-L1 Axis
EGFR-TKIs plus bevacizumab demonstrated survival benefit than EGFR-TKIs alone in patients with EGFR-mutant NSCLC and multiple brain metastases
A new glimpse of FadR-DNA crosstalk revealed by deep dissection of the E. coli FadR regulatory protein